Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Viridian Therapeutics To Host Webcast VRDN-001 Phase 3 THRIVE Topline Results On Sept. 10, 2024

Author: Benzinga Newsdesk | September 09, 2024 04:03pm

- THRIVE global phase 3 clinical trial evaluated efficacy and safety of VRDN-001 in patients with active thyroid eye disease (TED) -

- Conference call and webcast to be held Tuesday, September 10, at 8:00 a.m. ET -

Posted In: VRDN